Business Description
Founded in 2016 and headquartered in Seoul, South Korea, ABL Bio is a biotechnology company working to create new medicines that fight cancer and brain diseases. The company has built a pipeline of several drug candidates targeting solid tumors, blood cancers, and conditions such as Parkinson's disease, with a number of these treatments already progressing through early-stage clinical trials.
